Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer
Recruiting
Investigated Drugs:
+1
Study on [18F]PSMA-11 PET Imaging for Patients with Advanced Thyroid and Head and Neck Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study of Cetuximab and Avelumab for Patients with Recurrent or Metastatic Head and Neck Cancer with PD-L1 Score 1 or Higher
Recruiting
Investigated Diseases:
Prevention of radiation-induced salivary gland damage using botulinum toxin type A in patients with head and neck cancer
Not yet recruiting
Investigated Diseases:Investigated Drugs:
DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs:- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST TROP2 CONJUGATED TO N-((7S,15S)-7-BENZYL-17-(((1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL-10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12H-BENZO[DE]PYRANO[3′,4′:6,7] INDOLIZINO[1,2-B]QUINOLIN-1-YL)AMINO)-15-METHYL-2,5,8,11,17-PENTAOXO-14-OXA-3,6,9,12-TETRAAZAHEPTADECYL)-6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANAMIDE
- BNT327
Study of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases
Not yet recruiting
Investigated Diseases:Investigated Drugs:
A study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.
Not yet recruiting
Investigated Diseases:Investigated Drugs:
